$RKLB

Klein Frank sold $100K of RKLB

Klein Frank (Chief Operations Officer) sold 700 shares of Rocket Lab Corp (RKLB) at $143.05 ($0.10M total) on 2026-05-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Klein Frank
Published Jun 1, 2026, 10:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 10:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RKLB
Neutral
medium confidence
Mentioned
$RKLB
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBNeutralLow
01

Why it matters

The disclosure confirms the transaction details (700 shares, ~$143.05/share) and that it was executed under a pre-arranged 10b5-1 plan, which generally dampens interpretive value.

02

Market read

Traders may briefly check for insider-selling trends, but the 10b5-1 structure makes this more of a compliance datapoint than a catalyst.

03

What to watch

The sale size (~$100k) is small relative to typical large-cap market impact; without additional insider buys/sells or guidance changes, the trading signal is likely weak.

Relevance 6/10Novelty 6/10Timing: Filed today; sale executed 2026-05-28 (10b5-1 open-market sale).

Background

This is an SEC Form 4 insider transaction disclosure (officer/direct holdings) for Rocket Lab.

Company-level read

Ticker impact

$RKLBNeutralMedium confidence
Context

Rocket Lab COO Klein Frank sold 700 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed via Form 4.

Expected impact

Likely limited near-term impact; any reaction should be muted unless accompanied by unusual volume or other fundamental news.

Evidence & confidence

The filing provides a specific sale price/date and confirms a 10b5-1 plan, which typically lowers interpretive value for near-term fundamentals.

Market effects

Minor read-through for space/launch peers is possible, but this is a single-company insider transaction with low fundamental linkage.

None material indicated.

None material indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with management’s risk management or tax planning, which some traders may treat as a mild negative signal.

Key entities

  • Rocket Lab Corp

    Subject of the Form 4 insider transaction disclosure.

  • Klein Frank

    Chief Operations Officer who sold shares under a 10b5-1 plan.

Related articles

$RKLBMed

Rocket Lab wins three more Electron launch contracts from iQPS

Rocket Lab says it signed a multi-launch agreement with Japan’s iQPS for three additional dedicated Electron missions from Launch Complex 1 starting late 2027. Each launch will carry one QPS-SAR satellite to a 575 km low Earth orbit and use Rocket Lab’s Motorized Lightband separation system. Rocket Lab cites 18 Electron launches booked for iQPS and a 100% success rate since 2023.

$RKLBMedAI 8/10

Space Force invests millions in advanced threat detection 'flatellites'

The US Space Force is expanding threat detection under its SB-AMTI program, citing risks from anti-access/area-denial systems. It awarded Rocket Lab a $397 million deal to deploy “flatellites” in low Earth orbit. Another unnamed company received a $218 million contract, and SpaceX has a $4.16 billion agreement for a constellation, targeted for 2028.

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).

$RKLBMedAI 8/10

Rocket Lab (RKLB) Won a Major Space Force Contract. Now It Has to Prove Neutron

Rocket Lab (NASDAQ:RKLB) said Aug. 4 it won a $397 million U.S. Space Force contract under the SB-AMTI program to develop, launch and operate Flatellite satellites for airborne target tracking. The work depends on Rocket Lab’s Neutron rocket, whose first flight has been delayed to late 2026 after a Stage 1 tank failure. Rocket Lab reported Q1 FY2026 revenue of $200.3 million.

$RKLBMed

Why Rocket Lab Stock Just Jumped

Rocket Lab shares rose about 9.5% on Friday. The move followed another successful Electron launch from New Zealand, placing a satellite for a Japanese Earth-imaging customer into orbit. The stock also gained after Rocket Lab was selected for the $397 million U.S. Space Force SB-AMTI program to build, launch, and operate a satellite constellation.